TALPHERA, INC.

TLPH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008 FY2007 FY2006
Operating Activities
Net Income $-20.1M $-20.7M $-9.6M $-3.8M
Depreciation & Amortization $481.0K
Depreciation
Amortization
Stock-Based Compensation $463.0K
Net Cash from Operating Activities $-19.4M
Investing Activities
Capital Expenditures $111.0K
Business Acquisitions
Net Cash from Investing Activities $8.6M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $11.9M
Net Change in Cash $1.1M
Free Cash Flow $-19.5M
← Newer Page 3 of 3 Older →